Skip to content

Effects of different doses of theta burst stimulation on post-stroke aphasia

Effects of different doses of theta burst stimulation on post-stroke aphasia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062782
Enrollment
Unknown
Registered
2022-08-18
Start date
2022-08-15
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke aphasia

Interventions

Group 1:600 pulses cTBS
Group 2:1200 pulses cTBS
Group 3:1800 pulses cTBS

Sponsors

Beijing Boai Hospital, China Rehabilitation Research Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients met the diagnostic criteria of ischemic stroke or hemorrhagic stroke, and the course of disease was 1-6 months; 2. It meets the diagnostic criteria for aphasia, with an aphasia quotient of less than 93.8; 3. No obvious sequelae after first onset or previous onset; 4. 18-75 years old; 5. Before the onset of the disease, the language function is normal, and the mother tongue is Chinese, primary school education or above; 6. Patients and their family members understand the test and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Aphasia caused by brain tumor, Parkinson's disease, motor neurone disease and other neurological diseases other than stroke or brain trauma; 2. patients with cardiac pacemaker, cochlear implant or other metal foreign body and any electronic device implanted in the body, MRI scan contraindications such as claustrophobia, and TMS treatment contraindications; 3. a history of epilepsy (having at least two uninduced seizures more than 24 hours apart, or having seizures within the past 12 months); 4. Patients with serious systemic diseases of heart, lung, liver, kidney and other diseases that cannot be controlled by conventional medication after laboratory examination or examination; 5. patients with severe dysarthria, cognitive impairment, deafness, visual impairment and so on cannot cooperate with the test; 6. patients with severe depression or anxiety, or diagnosed with other mental diseases that make them unable to complete the test; 7. History of alcohol and drug abuse; 8. women who are pregnant or planning to become pregnant; 9. patients who had received TMS within the past 3 months; 10. Participants in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Western Aphasia Battery;

Countries

China

Contacts

Public ContactJingdu Zhao

Beijing Boai Hospital, China Rehabilitation Research Center

zjdklsa008@163.com+86 13696547715

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026